News
The latest edition of the renowned scientific meeting, held on 4–8 May in Brunnen (Switzerland), featured a strong presence from the CiQUS scientific community.
This recognition highlights his leadership of the ElectroMolMat research group at CiQUS.
His admission to the RAC makes him the first full member from the University of Santiago de Compostela in this institution.
Under the leadership of José Luis Mascareñas, the team will focus on the preclinical development of a promising chemical compound aimed at targeting cancer stem cells. The MEDiCS project, awarded €2.5 million in funding, was among 40 projects chosen from 416 proposals submitted in the most recent EIC Transition call in Europe.
The transition in leadership at CiQUS marks the beginning of a new era for the center, already established as a leading hub for research in Chemistry.
Researchers apply a methodology developed at CiQUS to test immunization against the hemorrhagic virus.